Company Profile
We are a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. We have a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine...
Volume:
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Innovative Procedural Solutions
Strengthened Distributor Partnerships
Improved Clinical Outcomes and Economic Value
Well capitalized to Execute Strategy
Q2 2021 Financial and Operational Highlights
74%
% of U.S. Spinal Implants Revenue from Recently Launched Products
2
Product Launches
64.5%
(+100 bps YOY)
(+100 bps YOY)
Adj. Gross Margin
$157.2M
Total Potential Liquidity